Showing 1 - 20 results of 22 for search 'Chad K. Porter', query time: 0.06s Refine Results
  1. 1
    The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites

    The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites by Jason Blitz, Mark S. Riddle, Mark S. Riddle, Chad K. Porter

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Review: chronic and persistent diarrhea with a focus in the returning traveler

    Review: chronic and persistent diarrhea with a focus in the returning traveler by Christopher A. Duplessis, Ramiro L. Gutierrez, Chad K. Porter

    Published 2017-05-01
    Get full text
    Article
  3. 3
    Travelers’ diarrhea: update on the incidence, etiology and risk in military and similar populations – 1990-2005 versus 2005–2015, does a decade make a difference?

    Travelers’ diarrhea: update on the incidence, etiology and risk in military and similar populations – 1990-2005 versus 2005–2015, does a decade make a difference? by Scott Olson, Alexis Hall, Mark S. Riddle, Chad K. Porter

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Update on Campylobacter vaccine development

    Update on Campylobacter vaccine development by Frédéric Poly, Alexander J. Noll, Mark S. Riddle, Chad K. Porter

    Published 2019-06-01
    Get full text
    Article
  5. 5
    Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents.

    Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents. by Brian Rha, Benjamin A Lopman, Ashley N Alcala, Mark S Riddle, Chad K Porter

    Published 2016-01-01
    Get full text
    Article
  6. 6
    Acute illness from Campylobacter jejuni may require high doses while infection occurs at low doses

    Acute illness from Campylobacter jejuni may require high doses while infection occurs at low doses by Peter F.M. Teunis, Axel Bonačić Marinović, David R. Tribble, Chad K. Porter, Arno Swart

    Published 2018-09-01
    Get full text
    Article
  7. 7
    A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries.

    A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries. by Tegan N Clarke, Megan A Schilling, Luca A Melendez, Sandra D Isidean, Chad K Porter, Frédéric M Poly

    Published 2021-01-01
    Get full text
    Article
  8. 8
    <i>Shigella</i> -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei

    <i>Shigella</i> -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei by Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, Robert W. Frenck, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Robert W. Kaminski

    Published 2021-08-01
    Get full text
    Article
  9. 9
    Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics

    Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and... by Chad K. Porter, Mark S. Riddle, Renee M. Laird, Matthew Loza, Suzanne Cole, Christina Gariepy, Ashley Alcala, Ramiro Gutierréz, Frédéric Baribaud, Navin L. Rao, Sunil Nagpal

    Published 2020-03-01
    Get full text
    Article
  10. 10
    A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CFA/I Fimbrial Tip Adhesin Antigens with and without Heat-Labile Enterotoxin with Mutation LT(R192G)

    A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CFA/I Fimbrial Tip Adhesin Antigens w... by Ramiro L. Gutiérrez, Mark S. Riddle, Chad K. Porter, Milton Maciel, Steven T. Poole, Renee M. Laird, Michelle Lane, George W. Turiansky, Abel Jarell, Stephen J. Savarino

    Published 2023-11-01
    Get full text
    Article
  11. 11
    Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics

    Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics by Chad K. Porter, Mark S. Riddle, Ramiro L. Gutierrez, Fred Princen, Rick Strauss, Shannon E. Telesco, Joana Torres, Rok Seon Choung, Renee M. Laird, Francisco Leon, Jean-Frédéric Colombel, Joseph A. Murray

    Published 2019-06-01
    Get full text
    Article
  12. 12
    Impact of international travel and diarrhea on gut microbiome and resistome dynamics

    Impact of international travel and diarrhea on gut microbiome and resistome dynamics by Manish Boolchandani, Kevin S. Blake, Drake H. Tilley, Miguel M. Cabada, Drew J. Schwartz, Sanket Patel, Maria Luisa Morales, Rina Meza, Giselle Soto, Sandra D. Isidean, Chad K. Porter, Mark P. Simons, Gautam Dantas

    Published 2022-12-01
    Get full text
    Article
  13. 13
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.

    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score. by Chad K Porter, Amanda Lynen, Mark S Riddle, Kawsar Talaat, David Sack, Ramiro L Gutiérrez, Robin McKenzie, Barbara DeNearing, Brittany Feijoo, Robert W Kaminski, David N Taylor, Beth D Kirkpatrick, A Louis Bourgeois

    Published 2018-01-01
    Get full text
    Article
  14. 14
    Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic <i>E. coli</i> H10407 in Healthy Adult Volunteers

    Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with... by Ramiro L. Gutiérrez, Chad K. Porter, Clayton Harro, Kawsar Talaat, Mark S. Riddle, Barbara DeNearing, Jessica Brubaker, Milton Maciel, Renee M. Laird, Steven Poole, Subra Chakraborty, Nicole Maier, David A. Sack, Stephen J. Savarino

    Published 2024-01-01
    Get full text
    Article
  15. 15
    Efficacy of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score

    Efficacy of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severi... by Nicole Maier, Shannon L. Grahek, Jane Halpern, Suzanne Restrepo, Felipe Troncoso, Janet Shimko, Olga Torres, Jaime Belkind-Gerson, David A. Sack, Ann-Mari Svennerholm, Björn Gustafsson, Björn Sjöstrand, Nils Carlin, A. Louis Bourgeois, Chad K. Porter

    Published 2023-09-01
    Get full text
    Article
  16. 16
    Establishment of a Controlled Human Infection Model with a Lyophilized Strain of <named-content content-type="genus-species">Shigella sonnei</named-content> 53G

    Establishment of a Controlled Human Infection Model with a Lyophilized Strain of <named-content content-type="genus-species">Shigella sonnei</named-content> 53G by Robert W. Frenck, Michelle Dickey, Akamol E. Suvarnapunya, Lakshmi Chandrasekaran, Robert W. Kaminski, Kristen A. Clarkson, Monica McNeal, Amanda Lynen, Susan Parker, Amy Hoeper, Sachin Mani, Alan Fix, Nicole Maier, Malabi M. Venkatesan, Chad K. Porter

    Published 2020-10-01
    Get full text
    Article
  17. 17
    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.

    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial. by Kawsar R Talaat, Chad K Porter, Kayla M Jaep, Christopher A Duplessis, Ramiro L Gutierrez, Milton Maciel, Brittany Adjoodani, Brittany Feijoo, Subhra Chakraborty, Jessica Brubaker, Stefanie A Trop, Mark S Riddle, Sabrina S Joseph, A Louis Bourgeois, Michael G Prouty

    Published 2020-01-01
    Get full text
    Article
  18. 18
    Immune Response Characterization after Controlled Infection with Lyophilized <named-content content-type="genus-species">Shigella sonnei</named-content> 53G

    Immune Response Characterization after Controlled Infection with Lyophilized <named-content content-type="genus-species">Shigella sonnei</named-content> 53G by Kristen A. Clarkson, Robert W. Frenck, Michelle Dickey, Akamol E. Suvarnapunya, Lakshmi Chandrasekaran, Hailey P. Weerts, Christopher D. Heaney, Monica McNeal, Kate Detizio, Susan Parker, Amy Hoeper, August L. Bourgeois, Chad K. Porter, Malabi M. Venkatesan, Robert W. Kaminski

    Published 2020-10-01
    Get full text
    Article
  19. 19
    Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention

    Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention by Kevin S. Blake, Drew J. Schwartz, Srinand Paruthiyil, Bin Wang, Jie Ning, Sandra D. Isidean, Daniel S. Burns, Harris Whiteson, Tahaniyat Lalani, Jamie A. Fraser, Patrick Connor, Tom Troth, Chad K. Porter, David R. Tribble, Mark S. Riddle, Ramiro L. Gutiérrez, Mark P. Simons, Gautam Dantas

    Published 2024-01-01
    Get full text
    Article
  20. 20
    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection by Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita M. Dreyer, Robert W. Kaminski, Chad K. Porter, Subhra Chakraborty, Kristen A. Clarkson, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey Weerts, Brittany L. Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck

    Published 2021-04-01
    Get full text
    Article

Search Tools: